56 related articles for article (PubMed ID: 12802033)
1. Clinical trials and rare diseases.
Lagakos SW
N Engl J Med; 2003 Jun; 348(24):2455-6. PubMed ID: 12802033
[No Abstract] [Full Text] [Related]
2. Confronting complexity in the design and conduct of high-risk rare disease clinical trials.
Stedman HH
Mol Ther; 2023 May; 31(5):1191-1192. PubMed ID: 37141855
[No Abstract] [Full Text] [Related]
3. Commentary on Harun et al.: The use of historical controls in randomized clinical trials.
George SL
Clin Trials; 2023 Jun; 20(3):235-236. PubMed ID: 36927257
[No Abstract] [Full Text] [Related]
4. The Value of the Information That Can Be Generated: Optimizing Study Design to Enable the Study of Treatments Addressing an Unmet Need for Rare Pathogens.
Dane A; Rex JH; Newell P; Stallard N
Open Forum Infect Dis; 2022 Jul; 9(7):ofac266. PubMed ID: 35854983
[TBL] [Abstract][Full Text] [Related]
5. Assessing the Value of Nusinersen for Spinal Muscular Atrophy: A Comparative Analysis of Reimbursement Submission and Appraisal in European Countries.
Blonda A; Barcina Lacosta T; Toumi M; Simoens S
Front Pharmacol; 2021; 12():750742. PubMed ID: 35126102
[No Abstract] [Full Text] [Related]
6. How to Value Orphan Drugs? A Review of European Value Assessment Frameworks.
Blonda A; Denier Y; Huys I; Simoens S
Front Pharmacol; 2021; 12():631527. PubMed ID: 34054519
[No Abstract] [Full Text] [Related]
7. From Pathogenesis to Novel Therapeutics for Spinocerebellar Ataxia Type 3: Evading Potholes on the Way to Translation.
Da Silva JD; Teixeira-Castro A; Maciel P
Neurotherapeutics; 2019 Oct; 16(4):1009-1031. PubMed ID: 31691128
[TBL] [Abstract][Full Text] [Related]
8. Orlistat Therapy for Children With Type 1 Hyperlipoproteinemia: A Randomized Clinical Trial.
Patni N; Quittner C; Garg A
J Clin Endocrinol Metab; 2018 Jun; 103(6):2403-2407. PubMed ID: 29659879
[TBL] [Abstract][Full Text] [Related]
9. An overview of the impact of rare disease characteristics on research methodology.
Whicher D; Philbin S; Aronson N
Orphanet J Rare Dis; 2018 Jan; 13(1):14. PubMed ID: 29351763
[TBL] [Abstract][Full Text] [Related]
10. Low-impact laparoscopic cholecystectomy is associated with decreased postoperative morbidity in patients with sickle cell disease.
de'Angelis N; Abdalla S; Carra MC; Lizzi V; Martínez-Pérez A; Habibi A; Bartolucci P; Galactéros F; Laurent A; Brunetti F
Surg Endosc; 2018 May; 32(5):2300-2311. PubMed ID: 29098436
[TBL] [Abstract][Full Text] [Related]
11. Innovative research methods for studying treatments for rare diseases: methodological review.
Gagne JJ; Thompson L; O'Keefe K; Kesselheim AS
BMJ; 2014 Nov; 349():g6802. PubMed ID: 25422272
[TBL] [Abstract][Full Text] [Related]
12. Development and use of new therapeutics for rare diseases: views from patients, caregivers, and advocates.
Kesselheim AS; McGraw S; Thompson L; O'Keefe K; Gagne JJ
Patient; 2015 Feb; 8(1):75-84. PubMed ID: 25362528
[TBL] [Abstract][Full Text] [Related]
13. Clinical studies in lysosomal storage diseases: Past, present, and future.
Boudes PF
Rare Dis; 2013; 1():e26690. PubMed ID: 25003011
[TBL] [Abstract][Full Text] [Related]
14. Clinical trials In BMT: ensuring that rare diseases and rarer therapies are well done.
Shurin S; Krischer J; Groft SC
Biol Blood Marrow Transplant; 2012 Jan; 18(1 Suppl):S8-11. PubMed ID: 22226117
[No Abstract] [Full Text] [Related]
15. A quantitative assessment of alkaptonuria: testing the reliability of two disease severity scoring systems.
Cox TF; Ranganath L
J Inherit Metab Dis; 2011 Dec; 34(6):1153-62. PubMed ID: 21744089
[TBL] [Abstract][Full Text] [Related]
16. Outcome of systemic sclerosis associated interstitial lung disease treated with intravenous cyclophosphamide.
Abhishek A; Yazdani R; Pearce F; Regan M; Lim K; Hubbard R; Lanyon P
Clin Rheumatol; 2011 Aug; 30(8):1099-104. PubMed ID: 21484227
[TBL] [Abstract][Full Text] [Related]
17. Policy alternatives for treatments for rare diseases.
Panju AH; Bell CM
CMAJ; 2010 Nov; 182(17):E787-92. PubMed ID: 20624867
[No Abstract] [Full Text] [Related]
18. Epidemiological and Outcomes Research in Children with Pediatric Cardiomyopathy: Discussions from the International Workshop on Primary and Idiopathic Cardiomyopathies in Children.
Lipshultz SE; Wilkinson JD
Prog Pediatr Cardiol; 2008 Apr; 25(1):23-25. PubMed ID: 19343085
[TBL] [Abstract][Full Text] [Related]
19. Clinical research for rare disease: opportunities, challenges, and solutions.
Griggs RC; Batshaw M; Dunkle M; Gopal-Srivastava R; Kaye E; Krischer J; Nguyen T; Paulus K; Merkel PA;
Mol Genet Metab; 2009 Jan; 96(1):20-6. PubMed ID: 19013090
[TBL] [Abstract][Full Text] [Related]
20. Challenges in the design and conduct of therapeutic trials in channel disorders.
Venance SL; Herr BE; Griggs RC
Neurotherapeutics; 2007 Apr; 4(2):199-204. PubMed ID: 17395129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
